$OPAD
Offerpad Solutions Inc. Stock $opad

$opad Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000095017023005066 Filed on February 28, 2023

Income Statement

Concept	2022 Q4	2022
Revenue	$677.2M	$3.952B
YoY Change	-21.94%	90.89%
Cost Of Revenue	$678.0M	$3.770B
YoY Change	-14.96%	102.4%
Gross Profit	-$760.0K	$182.4M
YoY Change	-101.08%	-12.22%
Gross Profit Margin	-0.11%	4.62%
Selling, General & Admin	$62.06M	$297.6M
YoY Change	-2.66%	67.98%
% of Gross Profit		163.17%
Research & Development	$2.978M	$12.09M
YoY Change	-6.85%	11.33%
% of Gross Profit		6.63%
Depreciation & Amortization	$258.0K	$1.022M
YoY Change	186.67%	104.4%
% of Gross Profit		0.56%
Operating Expenses	$65.04M	$309.7M
YoY Change	-2.86%	64.71%
Operating Profit	-$65.80M	-$127.3M
YoY Change	-2072.98%	-744.12%
Interest Expense	-$15.14M	$45.99M
YoY Change	144.98%	190.2%
% of Operating Profit
Other Income/Expense, Net	$4.221M	-$20.94M
YoY Change	-73.03%	59.39%
Pretax Income	-$120.8M	-$148.3M
YoY Change	-1043.41%	-2346.97%
Income Tax	$324.0K	$359.0K
% Of Pretax Income
Net Earnings	-$121.1M	-$148.6M
YoY Change	-1045.94%	-2400.51%
Net Earnings / Revenue	-17.89%	-3.76%
Basic Earnings Per Share		-$0.61
Diluted Earnings Per Share	-$0.49	-$0.61
COMMON SHARES
Basic Shares Outstanding		245.1M
Diluted Shares Outstanding		245.1M

Balance Sheet

Concept	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$97.24M	$97.24M
YoY Change	-42.74%	-42.74%
Cash & Equivalents	$97.24M
Short-Term Investments
Other Short-Term Assets	$49.89M	$49.89M
YoY Change	44.93%	44.93%
Inventory	$664.7M	$664.7M
Prepaid Expenses
Receivables	$2.350M	$2.350M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$814.2M	$814.2M
YoY Change	-39.38%	-39.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.194M	$10.66M
YoY Change	0.93%	7.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.696M	$227.0K
YoY Change	14.86%	29.71%
Total Long-Term Assets	$10.89M	$10.89M
YoY Change	7.77%	7.77%
TOTAL ASSETS
Total Short-Term Assets	$814.2M	$814.2M
Total Long-Term Assets	$10.89M	$10.89M
Total Assets	$825.1M	$825.1M
YoY Change	-39.02%	-39.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.647M	$4.647M
YoY Change	-27.38%	-27.38%
Accrued Expenses	$28.25M	$28.25M
YoY Change	-19.34%	-19.34%
Deferred Revenue
YoY Change
Short-Term Debt	$666.1M	$666.1M
YoY Change	-35.09%	-35.09%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$699.0M	$699.0M
YoY Change	-34.53%	-34.53%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.689M	$4.228M
YoY Change	-3.68%	-84.84%
Total Long-Term Liabilities	$3.689M	$4.228M
YoY Change	-3.68%	-84.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$699.0M	$699.0M
Total Long-Term Liabilities	$3.689M	$4.228M
Total Liabilities	$703.2M	$703.2M
YoY Change	-35.81%	-35.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$280.7M
YoY Change	112.54%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$121.9M	$121.9M
YoY Change
Total Liabilities & Shareholders Equity	$825.1M	$825.1M
YoY Change	-39.02%	-39.02%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$121.1M	-$148.6M
YoY Change	-1045.94%	-2400.51%
Depreciation, Depletion And Amortization	$258.0K	$1.022M
YoY Change	186.67%	104.4%
Cash From Operating Activities	$397.3M	$305.4M
YoY Change	-283.01%	-133.13%
INVESTING ACTIVITIES
Capital Expenditures	$153.0K	$1.070M
YoY Change	-296.15%	-92.18%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$153.0K	-$1.070M
YoY Change	96.15%	-90.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-480.5M	-358.5M
YoY Change	-274.77%	-133.28%
NET CHANGE
Cash From Operating Activities	397.3M	305.4M
Cash From Investing Activities	-153.0K	-1.070M
Cash From Financing Activities	-480.5M	-358.5M
Net Change In Cash	-83.37M	-54.13M
YoY Change	-244.3%	-137.67%
FREE CASH FLOW
Cash From Operating Activities	$397.3M	$305.4M
Capital Expenditures	$153.0K	$1.070M
Free Cash Flow	$397.2M	$304.3M
YoY Change	-283.0%	-132.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	dei	City Area Code CityAreaCode	844
CY2022	dei	Local Phone Number LocalPhoneNumber	388-4539
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	200800000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1064257000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	3769892000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1862631000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	976478000
CY2022	us-gaap	Gross Profit GrossProfit	182422000
CY2021	us-gaap	Gross Profit GrossProfit	207815000
CY2020	us-gaap	Gross Profit GrossProfit	87779000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	238931000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	146872000
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	76786000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	58718000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30317000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17481000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12090000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10860000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7270000
CY2022	us-gaap	Operating Expenses OperatingExpenses	309739000
CY2021	us-gaap	Operating Expenses OperatingExpenses	188049000
CY2020	us-gaap	Operating Expenses OperatingExpenses	101537000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-127317000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	19766000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-13758000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-23522000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2464000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0
CY2022	us-gaap	Interest Expense InterestExpense	45991000
CY2021	us-gaap	Interest Expense InterestExpense	15848000
CY2020	us-gaap	Interest Expense InterestExpense	10031000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1532000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	248000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	834000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20937000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13136000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9197000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-148254000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	359000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	170000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	163000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-148613000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6460000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23118000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	245148000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	118571000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57865000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	245148000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	143220000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57865000
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	154300000
CY2020	opad	Issuance Of Series C Stock Net Of Offering Costs IssuanceOfSeriesCStockNetOfOfferingCosts	29823000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1363000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23118000
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	184123000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-143258000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	647000
CY2021	opad	Vesting Of Early Exercised Stock Options VestingOfEarlyExercisedStockOptions	171000
CY2021	opad	Temporary Conversion Of Preferred Stock To Common Stock Amount TemporaryConversionOfPreferredStockToCommonStockAmount	-184123000
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	184123000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	206347000
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	257569000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4671000
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-57000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8307000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-148613000
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-132056000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	121877000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	257569000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	825069000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1353082000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3952314000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2070446000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	121877000
CY2022	us-gaap	Profit Loss ProfitLoss	-148613000
CY2021	us-gaap	Profit Loss ProfitLoss	6460000
CY2020	us-gaap	Profit Loss ProfitLoss	-23118000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1022000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	523000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	434000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	246000
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2948000
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	916000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	275000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5288000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-115000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1752000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4130000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	841000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-4402000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	21563000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1781000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	305402000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-921920000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	154864000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1070000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13687000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2858000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2032000
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1070000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11655000
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#NetIncomeLoss
CY2022	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#NetIncomeLoss
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.offerpad.com/20221231#AccruedAndOtherCurrentLiabilities
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.offerpad.com/20221231#AccruedAndOtherCurrentLiabilities
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001825024
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39641
CY2022	dei	Entity Registrant Name EntityRegistrantName	Offerpad Solutions Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2800538
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	2150 E. Germann Road
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Chandler
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2858000
CY2022	opad	Borrowings From Credit Facilities And Notes Payable BorrowingsFromCreditFacilitiesAndNotesPayable	3178033000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4898000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	902000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	285000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0
CY2022	opad	Proceeds From Business Combination ProceedsFromBusinessCombination	0
CY2021	opad	Proceeds From Business Combination ProceedsFromBusinessCombination	284011000
CY2020	opad	Proceeds From Business Combination ProceedsFromBusinessCombination	0
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-51249000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	262000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	93810000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	2843000
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	3170000
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85286
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	8307000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3079000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1363000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-23522000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2464000
CY2022	dei	Auditor Firm AuditorFirmId	34
CY2022	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2022	dei	Auditor Location AuditorLocation	Tempe, Arizona
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97241000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	169817000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	43058000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	24616000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2350000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6165000
CY2022Q4	us-gaap	Inventory Net InventoryNet	664697000
CY2021Q4	us-gaap	Inventory Net InventoryNet	1132571000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6833000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9808000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	814179000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1342977000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5194000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5146000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5696000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4959000
CY2022Q4	us-gaap	Assets Assets	825069000
CY2021Q4	us-gaap	Assets Assets	1353082000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4647000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6399000
CY2022Q4	opad	Accrued And Other Current Liabilities AccruedAndOtherCurrentLiabilities	28252000
CY2021Q4	opad	Accrued And Other Current Liabilities AccruedAndOtherCurrentLiabilities	35027000
CY2022Q4	opad	Secured Credit Facilities And Notes Payable SecuredCreditFacilitiesAndNotesPayable	605889000
CY2021Q4	opad	Secured Credit Facilities And Notes Payable SecuredCreditFacilitiesAndNotesPayable	861762000
CY2022Q4	opad	Secured Credit Facilities And Notes Payable Net Related Party SecuredCreditFacilitiesAndNotesPayableNetRelatedParty	60176000
CY2021Q4	opad	Secured Credit Facilities And Notes Payable Net Related Party SecuredCreditFacilitiesAndNotesPayableNetRelatedParty	164434000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	698964000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1067622000
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	539000
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	24061000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3689000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3830000
CY2022Q4	us-gaap	Liabilities Liabilities	703192000
CY2021Q4	us-gaap	Liabilities Liabilities	1095513000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	402521000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	389601000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-280669000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-3815000
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	3845000
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-937000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-374064000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	949591000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-169079000
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	29823000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-358466000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1077266000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-131147000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6630000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22955000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-54134000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	143691000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	20859000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	194433000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-121503000
CY2021	opad	Borrowings From Credit Facilities And Notes Payable BorrowingsFromCreditFacilitiesAndNotesPayable	2764071000
CY2020	opad	Borrowings From Credit Facilities And Notes Payable BorrowingsFromCreditFacilitiesAndNotesPayable	799997000
CY2022	opad	Repayments Of Credit Facilities And Notes Payable RepaymentsOfCreditFacilitiesAndNotesPayable	3540466000
CY2021	opad	Repayments Of Credit Facilities And Notes Payable RepaymentsOfCreditFacilitiesAndNotesPayable	1912837000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3079000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6460000
CY2020	opad	Repayments Of Credit Facilities And Notes Payable RepaymentsOfCreditFacilitiesAndNotesPayable	960510000
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	646000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50742000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29883000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140299000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	194433000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50742000
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	7632000
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	457000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97241000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	169817000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43938000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	46500000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	45300000
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	43058000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	24616000
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	6804000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140299000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	194433000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50742000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	59732000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	21875000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	14048000
CY2022	opad	Transfer Of Property And Equipment Net To Inventory TransferOfPropertyAndEquipmentNetToInventory	0
CY2021	opad	Transfer Of Property And Equipment Net To Inventory TransferOfPropertyAndEquipmentNetToInventory	14464000
CY2020	opad	Transfer Of Property And Equipment Net To Inventory TransferOfPropertyAndEquipmentNetToInventory	0
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	26525000
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	184123000
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Significant estimates include those related to the net realizable value of inventory, among others. Actual results could differ from those estimates.</span></p>
CY2020	us-gaap	Advertising Expense AdvertisingExpense	11500000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	500000
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;"> </span></p><p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Financial instruments that are potentially subject to concentrations of credit risk are primarily cash and cash equivalents. Cash and cash equivalents are placed with major financial institutions deemed to be of high-credit-quality in order to limit credit exposure. Cash is regularly maintained in excess of federally insured limits at the financial institutions. Management believes that the Company is not exposed to any significant credit risk related to cash deposits.</span></p>
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	400000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	93800000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	2800000
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	3200000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	300000
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2022	us-gaap	Derivatives Methods Of Accounting Nonhedging Derivatives DerivativesMethodsOfAccountingNonhedgingDerivatives	<p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Warrant Liabilities</span></p><p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The Company evaluates its financial instruments, including its outstanding warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company has outstanding public and private warrants, both of which do not meet the criteria for equity classification and are accounted for as liabilities. Accordingly, the Company recognizes the warrants as liabilities at fair value and adjusts the warrants to fair value at each reporting period. The warrant liabilities are subject to re-measurement at each balance sheet date until exercised or expired, and any change in fair value is recognized in the Company’s consolidated statements of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The fair value of the public warrants is estimated based on the quoted market price of such warrants on the valuation date. The fair value of the private warrants is estimated using the Black-Scholes-Merton option-pricing model. Refer to </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Note 8. Warrant Liabilities,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> for further details.</span></p>
CY2022	us-gaap	Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure	<p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Revenue is recognized when (or as) performance obligations are satisfied by transferring control of the promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services. The Company applies the following steps in determining the timing and amount of revenue to recognize: (1) identify the contract with our customer; (2) identify the performance obligation(s) in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract, if applicable; and (5) recognize revenue when (or as) the performance obligation is satisfied.</span></p><p style="margin-left:2.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Revenue from the sale of homes is derived from the resale of homes on the open market. Home sales revenue is recognized at the time of the closing when title to and possession of the property are transferred to the buyer. The amount of revenue recognized for each home sale is equal to the sale price of the home net of resale concessions and credits to the buyer.</span></p>
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	200000
CY2022	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.025
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1600000
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	1400000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1000000.0
CY2021Q3	opad	Proceeds From Business Combination ProceedsFromBusinessCombination	284000000.0
CY2021Q3	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	51200000
CY2021Q3	us-gaap	Repayments Of Debt RepaymentsOfDebt	63400000
CY2022Q4	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	54499000
CY2021Q4	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	327455000
CY2022Q4	us-gaap	Inventory Finished Homes InventoryFinishedHomes	440862000
CY2021Q4	us-gaap	Inventory Finished Homes InventoryFinishedHomes	400308000
CY2022Q4	opad	Inventory Homes Under Contract To Sell InventoryHomesUnderContractToSell	169336000
CY2021Q4	opad	Inventory Homes Under Contract To Sell InventoryHomesUnderContractToSell	404808000
CY2022Q4	us-gaap	Inventory Net InventoryNet	664697000
CY2021Q4	us-gaap	Inventory Net InventoryNet	1132571000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7685000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6615000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2491000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1469000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5194000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5146000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2022Q4	opad	Accrued And Other Current Liabilities AccruedAndOtherCurrentLiabilities	28252000
CY2021Q4	opad	Accrued And Other Current Liabilities AccruedAndOtherCurrentLiabilities	35027000
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2461000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2373000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1103000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	269000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	79000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6285000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	332000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5953000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5469000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4784000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2264000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1345000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3689000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3830000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5953000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5175000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10670000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12836000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4360000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3537000
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	4161000
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	5795000
CY2022Q4	opad	Accrued Home Renovation Payable Current AccruedHomeRenovationPayableCurrent	3168000
CY2021Q4	opad	Accrued Home Renovation Payable Current AccruedHomeRenovationPayableCurrent	8540000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2264000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1345000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1035000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1743000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2594000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1231000
CY2022Q4	us-gaap	Secured Debt Other SecuredDebtOther	89024000
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2021Q4	us-gaap	Secured Debt Other SecuredDebtOther	33320000
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4621000
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6923000
CY2022Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	666065000
CY2021Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1026196000
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	605889000
CY2021Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	861762000
CY2022Q4	opad	Notes And Loans Payable Related Parties Current NotesAndLoansPayableRelatedPartiesCurrent	60176000
CY2021Q4	opad	Notes And Loans Payable Related Parties Current NotesAndLoansPayableRelatedPartiesCurrent	164434000
CY2022Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	666065000
CY2021Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1026196000
CY2022	opad	Warrantsexpirationperiodaftercompletionofbusinesscombinationorearlieruponredemptionorliquidationdate Warrantsexpirationperiodaftercompletionofbusinesscombinationorearlieruponredemptionorliquidationdate	2026-09-01
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2022Q4	opad	Shares Authorized SharesAuthorized	2370000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	23669000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.55
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M15D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	16275000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5258000
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.22
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1336000
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.54
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	245148000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	143220000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27591000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.68
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	14619000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1559000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.22
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2490000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.36
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1084000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.85
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	25576000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.73
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M25D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	137170000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1147000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.90
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	8101000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.58
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	895000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.46
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17727000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.02
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y9M25D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	953000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	14122000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.72
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y2M26D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	953000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	17727000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.02
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y9M25D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	953000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	35800000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10500000
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.73
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.60
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.61
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3500000
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y11M23D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2100000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2600000
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1200000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57865000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2022	us-gaap	Dilutive Securities DilutiveSecurities	0
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	0
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8307000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3079000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1363000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-148613000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6460000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23118000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	245148000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	118571000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57865000
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	24644000
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2022	opad	Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnits	0
CY2021	opad	Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnits	5000
CY2020	opad	Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnits	0
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0
CY2020	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2020	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-148300000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6600000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23000000.0
CY2022	opad	Transaction Costs Percentage TransactionCostsPercentage	0.013
CY2021	opad	Transaction Costs TransactionCosts	-1226000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	359000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	170000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	163000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	359000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	170000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	163000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	359000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	170000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	163000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-31133000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1392000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4821000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-7636000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.052
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	360000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.054
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-446000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.019
CY2022	opad	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilities	-4940000
CY2022	opad	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities Percentage EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilitiesPercentage	0.033
CY2021	opad	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilities	-517000
CY2021	opad	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities Percentage EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilitiesPercentage	-0.078
CY2020	opad	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilities	0
CY2020	opad	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liabilities Percentage EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilitiesPercentage	0.000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	-2277000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	0.015
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	221000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	0.033
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	218000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	-0.009
CY2021	opad	Transaction Costs Percentage TransactionCostsPercentage	-0.185
CY2020	opad	Transaction Costs TransactionCosts	0
CY2020	opad	Transaction Costs Percentage TransactionCostsPercentage	0.000
CY2022	opad	Transaction Costs TransactionCosts	1874000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	739000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	874000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1019000
CY2022	opad	Effective Income Tax Rate Reconciliation At Incentive Stock Options Amount EffectiveIncomeTaxRateReconciliationAtIncentiveStockOptionsAmount	-1091000
CY2022	opad	Effective Income Tax Rate Reconciliation Of Incentive Stock Options EffectiveIncomeTaxRateReconciliationOfIncentiveStockOptions	-0.007
CY2021	opad	Effective Income Tax Rate Reconciliation At Incentive Stock Options Amount EffectiveIncomeTaxRateReconciliationAtIncentiveStockOptionsAmount	647000
CY2021	opad	Effective Income Tax Rate Reconciliation Of Incentive Stock Options EffectiveIncomeTaxRateReconciliationOfIncentiveStockOptions	0.098
CY2020	opad	Effective Income Tax Rate Reconciliation At Incentive Stock Options Amount EffectiveIncomeTaxRateReconciliationAtIncentiveStockOptionsAmount	286000
CY2020	opad	Effective Income Tax Rate Reconciliation Of Incentive Stock Options EffectiveIncomeTaxRateReconciliationOfIncentiveStockOptions	-0.012
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	48690000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.328
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-675000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.102
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4999000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.218
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-620000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.004
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	32000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.004
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	73000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.003
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	359000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	170000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.026
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	163000
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.007
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	50178000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	26721000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	9847000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	4703000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	14771000
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	341000
CY2022Q4	opad	Deferred Tax Assets Research And Development Expenditures DeferredTaxAssetsResearchAndDevelopmentExpenditures	3190000
CY2021Q4	opad	Deferred Tax Assets Research And Development Expenditures DeferredTaxAssetsResearchAndDevelopmentExpenditures	0
CY2022Q4	opad	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	1852000
CY2021Q4	opad	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	0
CY2022Q4	opad	Deferred Tax Assets Transaction Costs DeferredTaxAssetsTransactionCosts	1707000
CY2021Q4	opad	Deferred Tax Assets Transaction Costs DeferredTaxAssetsTransactionCosts	0
CY2022Q4	opad	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	1507000
CY2021Q4	opad	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	1284000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2117000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2421000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	85169000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	35470000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	82026000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	33336000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3143000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	73000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3143000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2134000
CY2022Q4	opad	Deferred Tax Liabilities Operating Lease Right Of Use Asset DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset	-1385000
CY2021Q4	opad	Deferred Tax Liabilities Operating Lease Right Of Use Asset DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset	-1187000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2134000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	48700000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-700000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5000000.0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022	us-gaap	Related Party Costs RelatedPartyCosts	1348000
CY2021	us-gaap	Related Party Costs RelatedPartyCosts	1182000
CY2020	us-gaap	Related Party Costs RelatedPartyCosts	693000
CY2022Q4	opad	Contractual Obligation To Purchase Home ContractualObligationToPurchaseHome	98
CY2022Q4	us-gaap	Contractual Obligation ContractualObligation	24900000
CY2022Q4	us-gaap	Purchase Obligation PurchaseObligation	6500000
CY2022Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	5800000

Files In Submission

Name	View Source	Status
opad-20221231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0000950170-23-005066-index-headers.html	Edgar Link	pending
0000950170-23-005066-index.html	Edgar Link	pending
0000950170-23-005066.txt	Edgar Link	pending
0000950170-23-005066-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img221734950_0.jpg	Edgar Link	pending
img221734950_1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opad-20221231.htm	Edgar Link	pending
opad-20221231.xsd	Edgar Link	pending
opad-ex10_23.htm	Edgar Link	pending
opad-ex10_29.htm	Edgar Link	pending
opad-ex10_30.htm	Edgar Link	pending
opad-ex21_1.htm	Edgar Link	pending
opad-ex23_1.htm	Edgar Link	pending
opad-ex31_1.htm	Edgar Link	pending
opad-ex31_2.htm	Edgar Link	pending
opad-ex32_1.htm	Edgar Link	pending
opad-ex32_2.htm	Edgar Link	pending
opad-20221231_def.xml	Edgar Link	unprocessable
opad-20221231_lab.xml	Edgar Link	unprocessable
opad-20221231_pre.xml	Edgar Link	unprocessable
opad-20221231_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPAD
Offerpad Solutions Inc. Stock $opad

2022 Q4 Form 10-K Financial Statement

#000095017023005066 Filed on February 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPAD Offerpad Solutions Inc. Stock $opad

2022 Q4 Form 10-K Financial Statement

#000095017023005066 Filed on February 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPAD
Offerpad Solutions Inc. Stock $opad